We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Alexion Pharmaceuticals Inc | NASDAQ:ALXN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 182.50 | 183.00 | 185.00 | 0 | 01:00:00 |
Alexion Pharmaceuticals, Inc. (ALXN) is currently at $123.73, up $8.89, or 7.74%
-- Would be highest close since July 10 when it closed at $124.37
-- On pace for largest percent increase since April 26, 2018, when it rose 14.5%
-- Earlier Thursday, Spanish business news website Intereconomia reported that Amgen Inc. is poised to buy Alexion Pharmaceuticals Inc. for about $45 billion, renewing speculation on a potential deal that has been rumored for more than a year
-- Currently up five of the past six days
-- Currently up two consecutive days; up 11.04% over this period
-- Best two-day stretch since the two days ending April 27, 2018, when it rose 14.46%
-- Up 9.22% month-to-date
-- Up 27.09% year-to-date
-- Down 40.47% from its all-time closing high of $207.84 on July 23, 2015
-- Traded as high as $125.52; highest intraday level since July 10 when it hit $127.74
-- Up 9.3% at Thursday's intraday high; largest intraday percent increase since April 26, 2018, when it rose as much as 16.24%
-- Third-best performer in the S&P 500 Thursday
-- Best performer in the Nasdaq 100 Thursday
All data as of 3:25 p.m. EDT
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 22, 2019 15:53 ET (19:53 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year Alexion Pharmaceuticals Chart |
1 Month Alexion Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions